share_log

D. Boral Capital Maintains Buy on FibroBiologics, Maintains $16 Price Target

Benzinga ·  Apr 1 11:04

D. Boral Capital analyst Jason Kolbert maintains FibroBiologics (NASDAQ:FBLG) with a Buy and maintains $16 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 354
Write a comment